Clover Health Investments Overview
Latest P/E ratio for Clover Health Investments: -104.44 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-104.44
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, CLOV shows a P/E ratio of -104.44. That is below the Finance sector average of 16.51. Scroll down for historical charts and peer comparison views.
The Finance sector average P/E ratio is about 16.51. Clover Health Investments is at -104.44, which is lower that average. That is roughly 732.5% below the sector mean. Use the comparison chart on this page to see how CLOV stacks up against individual peers as well.
Investors watch CLOV's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Clover Health Investments's latest reading is -104.44. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Clover Health Investments's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -104.44) with ownership activity and broader fundamentals.
The Finance average P/E ratio is about 16.51, while CLOV is at -104.44. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
